Discovery of high quality molecular leads and screening collections for CNS drug targets
Diseases of the central nervous system represent an increasing area of unmet medical need. Despite high levels of investment from the pharmaceutical industry few disease modifying drugs have been discovered with the most common cause of late stage clinical failure being a lack of efficacy. In order...
Saved in:
Main Author | |
---|---|
Format | Dissertation |
Language | English |
Published |
University of Dundee
2019
|
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!